We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Allos' PDX Designated an Orphan Drug by FDA
Allos' PDX Designated an Orphan Drug by FDA
July 26, 2006
The FDA has granted orphan drug status to Allos’ T-cell lymphoma drug PDX, the company said July 26.